BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
2928 results:

  • 1. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
    Shastri SS; McNeill LH; Shete S
    JCO Glob Oncol; 2024 May; 10():e2400005. PubMed ID: 38723214
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
    Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
    PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
    Friedman CF; Manning-Geist BL; Zhou Q; Soumerai T; Holland A; Da Cruz Paula A; Green H; Ozsoy MA; Iasonos A; Hollmann T; Leitao MM; Mueller JJ; Makker V; Tew WP; O'Cearbhaill RE; Liu YL; Rubinstein MM; Troso-Sandoval T; Lichtman SM; Schram A; Kyi C; Grisham RN; Causa Andrieu P; Wherry EJ; Aghajanian C; Weigelt B; Hensley ML; Zamarin D
    Nat Med; 2024 May; 30(5):1330-1338. PubMed ID: 38653864
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Knowledge of cytology results affects the performance of colposcopy: a crossover study.
    Lalande E; Clarke H; Undurraga M; Nguyen VQH; Jaksic C; Goffin F; Arbyn M; Jeronimo J; Tille JC; Saiji E; Vassilakos P; Petignat P
    BMC Womens Health; 2024 Mar; 24(1):189. PubMed ID: 38515088
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
    Santoro A; Bragantini E; Castiglione F; Ganesan R; Matias-Guiu X; Frattini M; Gallotta V; Garcia P; Pattni Y; Tsiampali-Laprell J; Bisaro B; Barbareschi M; Zannoni GF;
    Pathologica; 2024 Feb; 116(1):32-45. PubMed ID: 38482673
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
    Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
    Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
    Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
    Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
    Khushman MM; Toboni MD; Xiu J; Manne U; Farrell A; Lou E; Shields AF; Philip PA; Salem ME; Abraham J; Spetzler D; Marshall J; Jayachandran P; Hall MJ; Lenz HJ; Sahin IH; Seeber A; Powell MA
    Clin Cancer Res; 2024 May; 30(9):1906-1915. PubMed ID: 38350001
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes.
    Yoshida H; Matsuo K; Machida H; Matsuzaki S; Maeda M; Terai Y; Fujii T; Mandai M; Kawana K; Kobayashi H; Mikami M; Nagase S
    Int J Gynecol Cancer; 2024 Apr; 34(4):510-518. PubMed ID: 38316444
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
    Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
    Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Fokom Domgue J; Dille I; Kapambwe S; Yu R; Gnangnon F; Chinula L; Murenzi G; Mbatani N; Pande M; Sidibe F; Kamgno J; Traore B; Fazazi HE; Diop M; Tebeu PM; Diomande MI; Lecuru F; Adewole I; Plante M; Basu P; Dangou JM; Shete S
    Front Public Health; 2024; 12():1343064. PubMed ID: 38299075
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
    Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
    Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Next-generation sequencing and immunohistochemistry approaches for microsatellite instability detection in endometrial cancer.
    Ali AS; Alalem LS
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):237-242. PubMed ID: 38279425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
    Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
    Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
    Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. New Insights into Lynch Syndrome: A Narrative Review.
    Ene CV; Bulai CTLA; Geavlete P; Popescu RI; Vacaroiu IA; Georgescu DE; Isaconi IV; Munteanu MDLA; Ene CD; Militaru A; Geavlete B; Multescu R
    Chirurgia (Bucur); 2023 Dec; 118(6):584-595. PubMed ID: 38228591
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
    BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
    Kaya M; Post CCB; Tops CM; Nielsen M; Crosbie EJ; Leary A; Mileshkin LR; Han K; Bessette P; de Boer SM; Jürgenliemk-Schulz IM; Lutgens L; Jobsen JJ; Haverkort MAD; Nout RA; Kroep J; Creutzberg CL; Smit VTHBM; Horeweg N; van Wezel T; Bosse T
    Mod Pathol; 2024 Mar; 37(3):100423. PubMed ID: 38191122
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 147.